Novartis Ag Earnings

Novartis Ag’s revenue jumped 15.14% since last year same period to $13620Mn in the Q1 2025. On a quarterly growth basis, Novartis Ag has generated 0.46% jump in its revenue since last 3-months.

Novartis Ag’s net profit jumped 34.15% since last year same period to $3606Mn in the Q1 2025. On a quarterly growth basis, Novartis Ag has generated 27.96% jump in its net profits since last 3-months.

Novartis Ag’s net profit margin jumped 16.51% since last year same period to 26.48% in the Q1 2025. On a quarterly growth basis, Novartis Ag has generated 27.38% jump in its net profit margins since last 3-months.

Novartis Ag’s price-to-earnings ratio after this Q1 2025 earnings stands at 18.18.

Novartis Ag’s earning per share (EPS) estimates for the current quarter stand at 2.13 - a 17.68% jump from last quarter’s estimates.

Novartis Ag’s earning per share (EPS) estimates for the current year stand at 2.13.

Novartis Ag’s earning per share (EPS) jumped 26.67% since last year same period to 2.28 in the Q1 2025. This indicates that the Novartis Ag has generated 26.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Novartis Ag’s return on assets (ROA) stands at 0.11.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Novartis Ag’s return on equity (ROE) stands at 0.33.

Novartis Ag declared 3.87 dividend per share during the earnings announcement for Q1 2025.